G948-0032 Screening compound: N-[(2-chlorophenyl)methyl]-1-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide

G948-0032 Screening compound: N-[(2-chlorophenyl)methyl]-1-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide
G948-0032 Screening compound: N-[(2-chlorophenyl)methyl]-1-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G948-0032
N-[(2-chlorophenyl)methyl]-1-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G948-0032

Molecular Formula

C22H23ClN4O4S (C22 H23 ClN4 O4 S)

Compound Name

N-[(2-chlorophenyl)methyl]-1-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide

IUPAC name

N-[(2-chlorophenyl)methyl]-1-[3-(5-methyl-124-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide

SMILES

Cc1nc(-c2cccc(S(N(CC3)CCC3C(NCc(cccc3)c3Cl)=O)(=O)=O)c2)no1

InChI

InChI=1S/C22H23ClN4O4S/c1-15-25-21(26-31-15)17-6-4-7-19(13-17)32(29,30)27-11-9-16(10-12-27)22(28)24-14-18-5-2-3-8-20(18)23/h2-8,13,16H,9-12,14H2,1H3,(H,24,28)

InChI Key

QASPJNZPSOFJDT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15076913

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

474.97

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.627

Distribution Coefficient, logD

3.627

Water Solubility, LogSw

-4.01

Polar Surface Area

87.268

Acid Dissociation Constant (pKa)

12.56

Base Dissociation Constant (pKb)

-2.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

G948-0032 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G948-0032 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G948-0032?
Check Price and Availability of G948-0032, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G948-0032 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G948-0032
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G948-0032
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G948-0032 available by request